Ovarian Overproduction of Androgens Treatments

Find Ovarian Overproduction of Androgens Treatments

Generic Name

Norethindrone Acetate

Brand Names

24FE, Abigale, Activella, Affodel, Alyacen, Aranelle, Aurovela, Aurovela 24, Balziva, Blisovi, Blisovi 24, Briellyn, Camila, Cyonanz, Dasetta, Deblitane, Emzahh, ERRIN, Etyqa, Feirza, Femlyv, Finzala, Fyavolv, Galbriela, Gallifrey, Hailey, Hailey 24, Incassia, Jencycla, Jinteli, Junel, Junel 21, Kaitlib, Loestrin, Loestrin 21, Lopreeza, Luizza, Lyleq, Meleya, Melodetta 24, Mibelas 24, Microgestin, Microgestin 24, Mimvey, Myfembree, Necon, Nexesta, Norethindrone, Nortrel, Nortrel 21, Nortrel 28, Nylia, Orquidea, OSHIH, Philith, Rhuzdah, Sharobel, Tarina, Tarina 24, Taytulla, Tri-Legest, Vyfemla, Wera, Wymzya, XARAH, Xelria, Zenchent

FDA approval date: May 25, 2001

Classification: Progestin

Form: Tablet, Kit

What is 24FE (Norethindrone Acetate)?

Charlotte 24 Fe is indicated for use by females of reproductive age to prevent pregnancy. The efficacy of Charlotte 24 Fe in women with a body mass index of more than 35 kg/m 2 has not been evaluated. Charlotte 24 Fe is a combination of norethindrone acetate, a progestin, and ethinyl estradiol, an estrogen, indicated for use by females of reproductive potential to prevent pregnancy , The efficacy in females of reproductive potential with a body mass index of more than 35 kg/m 2 has not been evaluated ( 1.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

A Phase II Study of Sequential Bipolar Androgen Therapy and ZEN-3694 in Sequence With Enzalutamide + ZEN-3694 in Asymptomatic Patients With Metastatic CRPC: The COSMYC Trial (COmbined Suppression of MYC)

Enrollment Status: Recruiting

Publish Date: June 18, 2026

Intervention Type: Drug

Study Phase: Phase 2

Summary: This research is being done to determine if receiving the combination of testosterone and ZEN-3694 followed by the combination of enzalutamide plus ZEN-3694 will decrease the size of tumors in patients with prostate cancer that has become resistant to castration and other therapies. The investigators also want to determine if dosing first with the combination of testosterone and ZEN-3694 may cause...

Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients With Post-ProstaTEctomy Biochemical Recurrence (INDICATE)

Who is this study for: Adult patients with prostate cancer

Enrollment Status: Recruiting

Publish Date: June 18, 2026

Intervention Type: Procedure, Drug, Radiation, Other

Study Drugs: Apalutamide, Goserelin acetate, Leuprolide acetate

Study Phase: Phase 3

Summary: This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurre...

The Effect of Medical Management Following Excisional Surgery for Endometriosis: A Randomized Controlled Trial

Enrollment Status: Recruiting

Publish Date: June 12, 2026

Intervention Type: Drug

Study Phase: Phase 3

Summary: The goal of this investigator-initiated single-site clinical trial is to compare the overall quality of life of participants taking Relugolix combination therapy (Rel-CT) following excisional surgery for endometriosis to participants that do not take Rel-CT following the same surgery. Rel-CT is an FDA approved form of medical treatment for endometriosis. It is known to work in treating endometrios...

View All Clinical Trials